- Oppenheimer initiated coverage of ANI Pharmaceuticals (NASDAQ:ANIP)
- Rating: Perform (equivalent to Hold)
Oppenheimer started coverage on ANI Pharmaceuticals with a Perform rating. No price target was disclosed. The initiation offers a neutral starting view for the small-cap drugmaker.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.